Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

From genomics to drug targets.

Svein G Dahl1, Ingebrigt Sylte

  • 1Department of Pharmacology, Institute of Medical Biology, University of Tromsø, Tromsø, Norway. sgd@fagmed.uit.no

Journal of Psychopharmacology (Oxford, England)
|June 21, 2006
PubMed
Summary

Understanding drug targets requires distinguishing receptors from other proteins. Molecular modeling of neurotransmitter receptors and transporters reveals their structural flexibility and conformational changes, crucial for psychotropic drug action.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of novel <i>N</i>-benzyloxy-amino acid hydroxamates as inhibitors of the virulence factor LasB from <i>Pseudomonas aeruginosa</i>.

RSC medicinal chemistry·2025
Same author

Interactions of substrates and phosphinyl containing inhibitors with bacterial and human zinc proteases.

PloS one·2025
Same author

Identification of Orthosteric GABA<sub>B</sub> Receptor Ligands by Virtual Screening and <i>In Vitro</i> Validation.

ACS omega·2025
Same author

Homology Modeling of Transporter Proteins.

Methods in molecular biology (Clifton, N.J.)·2023
Same author

Zinc-Chelating Compounds as Inhibitors of Human and Bacterial Zinc Metalloproteases.

Molecules (Basel, Switzerland)·2022
Same author

Specific interactions between the alkaline protease of P. aeruginosa and its natural peptide inhibitor: ab initio molecular simulations.

Journal of molecular modeling·2021

Area of Science:

  • Biochemistry
  • Pharmacology
  • Structural Biology

Background:

  • Molecular biology advances distinguish drug receptors from other molecular targets like enzymes and transporters.
  • Proteins constitute over 95% of current therapeutic drug targets, with the human genome revealing numerous new potential targets.
  • Understanding protein 3D structure is key to elucidating functional mechanisms, achievable through experimental and computational methods.

Purpose of the Study:

  • To model neurotransmitter receptors and transporters using molecular modeling techniques.
  • To investigate the structural properties and functional mechanisms of these membrane proteins.
  • To elucidate the molecular mechanisms of action for psychotropic drugs targeting these proteins.

Main Methods:

  • Utilized molecular modeling based on existing crystal structures of related proteins.
  • Modeled various neurotransmitter receptors and transporters.
  • Analyzed structural properties, functional mechanisms, and drug interactions through computational methods.

Main Results:

  • Successfully modeled diverse neurotransmitter receptors and transporters.
  • Demonstrated significant structural flexibility in transporter and receptor proteins.
  • Observed substantial conformational changes during substrate translocation and agonist-induced stimulation.

Conclusions:

  • Molecular modeling provides insights into the structure and function of challenging membrane proteins like receptors and transporters.
  • The identified structural flexibility is critical for understanding the dynamic mechanisms of drug action.
  • These findings advance the study of psychotropic drug mechanisms and the development of new therapeutics.

Related Experiment Videos